Add BrightSurf on Google Email

Singapore scientists unveil one of world’s largest long-read RNA sequencing datasets to advance disease research

A team of Singaporean scientists has released a comprehensive long-read RNA sequencing dataset, SG-NEx, to accelerate biomarker discovery and precision medicine. The dataset offers deeper biological insights into RNA complexity, enabling researchers to detect clinically relevant biomarkers and develop better treatments.

New research lays groundwork for early detection of Alzheimer’s disease

A new study from Columbia University Mailman School of Public Health found significant associations between cognition and established risk factors for Alzheimer's disease in individuals aged 24-44. The researchers used biomarkers related to cognitive impairment and cardiovascular health to predict long-term trajectories of cognitive de...

Hereditary Alzheimer’s: Blood marker for defective neuronal connections rises early

A study has identified an early blood marker for hereditary Alzheimer's disease, beta-synuclein, which can detect neurodegeneration up to 11 years before dementia symptoms. This biomarker could help with early diagnosis and treatment, improving the potential of new medicines for Alzheimer's.

SourceDZNE - German Center for Neurodegenerative Diseases·JournalAlzheimer s & Dementia·TypeObservational study·DateApr 16, 2025

Blood test may rule out future dementia risk

A new study published in Nature Medicine has investigated the potential of specific biomarkers to predict dementia risk up to ten years before diagnosis. The study found that low levels of certain biomarkers may rule out future dementia, but elevated levels alone are not reliable for identification.

SourceKarolinska Institutet·JournalNature Medicine·TypeData/statistical analysis·DateApr 2, 2025

Older adults experience similar or even less muscle damage than young adults after exercise

A recent study published in the Journal of Ageing and Physical Activity found that older adults exhibit similar or even less muscle damage than young adults after exercise. Muscle soreness was consistently lower in older adults, with reductions of around 34% at 48 hours and 62% at 72 hours compared to younger individuals.

SourceLancaster University·JournalJournal of Aging and Physical Activity·TypeMeta-analysis·DateApr 2, 2025

Association for Molecular Pathology celebrates U.S. District Court’s decision to vacate FDA rule on laboratory-developed test procedure regulation

The Association for Molecular Pathology (AMP) has won a court ruling that vacates the FDA's rule on laboratory-developed test procedure regulation. This decision will avoid adding billions of dollars in healthcare costs and protect access to high-quality care for hundreds of millions of Americans.

Joint consensus highlights the role of bone turnover markers in osteoporosis diagnosis and management

A new consensus paper emphasizes the role of bone turnover markers (BTMs) in diagnosing and managing osteoporosis. BTMs, such as procollagen type I N propeptide (PINP) and β-isomerized C-terminal telopeptide of type I collagen (β-CTX-I), are invaluable tools for predicting fracture risk and monitoring treatment adherence.

SourceInternational Osteoporosis Foundation·JournalOsteoporosis International·TypeLiterature review·DateMar 31, 2025

Revolutionizing protein modification: a new frontier in cancer research

A team of scientists has created a new method to selectively modify specific proteins in complex biological environments. They achieved this using aptamers and deoxyoxanosine, allowing precise conjugation of desired sites on target proteins. This breakthrough technology has the potential to revolutionize cancer diagnosis and treatment.

SourcePohang University of Science & Technology (POSTECH)·JournalJournal of the American Chemical Society·DateMar 26, 2025

UTEP Researchers develop portable, blood-based device that detects colon cancer

Researchers at the University of Texas at El Paso have developed a portable, blood-based device that can detect colon cancer using a biomarker called CCSP-2. The device has the potential to provide early detection and treatment options for this second-deadliest US cancer, making it a significant advancement in colorectal cancer screening.

SourceUniversity of Texas at El Paso·JournalACS Measurement Science Au·DateMar 13, 2025

USC study shows proteins and pathways involved in inflammation are associated with changes in bone mineral density over time

A USC study found proteins and pathways involved in inflammation are associated with changes in bone mineral density (BMD) over time. The research identified potential biomarkers that could serve as early indicators of a person's risk for bone health issues later in life.

SourceKeck School of Medicine of USC·JournalJournal of Bone and Mineral Research·TypeMeta-analysis·DateMar 13, 2025

Blood test shows promise for early detection of dementia

Researchers have discovered a blood test that can identify patients with a sleep disorder who are most likely to develop Dementia with Lewy Bodies. The blood test analyzes two proteins in the blood associated with Alzheimer's disease and predicted dementia risk in almost 90% of patients, four years before symptoms appeared.

SourceMcGill University·JournalBrain·DateMar 11, 2025

Diagnosing Alzheimer’s disease using blood tests: p-tau biomarkers not as disease-specific as previously thought

Researchers found that p-tau proteins in blood are elevated in both Alzheimer's and ALS patients, making them less specific for Alzheimer's diagnosis. However, they also show promise as potential biomarkers for early detection of ALS or monitoring disease progression.

SourceMartin-Luther-Universität Halle-Wittenberg·JournalNature Communications·TypeObservational study·DateMar 6, 2025

Innovative CT scan technique could improve prognosis and treatments for head and neck cancers, new research suggests

Researchers analyzed pre-treatment CT scans of patients with head and neck squamous cell carcinoma to identify radiomic biomarkers that can predict the aggressiveness of the disease and its response to treatment. These biomarkers may lead to more targeted therapies and improved survival outcomes for patients.

SourceUniversity of Maryland School of Medicine·JournalScientific Reports·TypeData/statistical analysis·DateFeb 26, 2025

Alzheimer's disease, dementias chronically undiagnosed yet early detection rarely used

Only about 1 in 5 older Americans have undergone cognitive screening in the past year, highlighting a persistent barrier to diagnosis and treatment. Researchers emphasize the importance of early conversations about cognitive health to prevent progression and improve outcomes.

SourceUniversity of Michigan School of Public Health·JournalAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·DateFeb 20, 2025

New research brings hope for improved outcomes and survival rates for patients facing a pancreatic cancer diagnosis

Researchers at Trinity College Dublin have discovered a biomarker panel that can accurately identify patients at risk of developing pancreatic cancer, offering new hope for early detection and improved treatment. The study uses a combination of blood and fluid analysis to distinguish between low- and high-risk patients.

SourceTrinity College Dublin·JournalScientific Reports·TypeExperimental study·DateFeb 18, 2025

New blood test could improve Alzheimer’s Disease diagnosis, research finds

A new blood test has shown promise in improving the accuracy of Alzheimer's Disease diagnosis, with results comparable to established CSF biomarkers. The study found that measuring plasma p-tau217 was over 90% accurate, potentially replacing invasive diagnostic methods for up to half of patients.

SourceTrinity College Dublin·JournalAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·TypeExperimental study·DateFeb 14, 2025

IR Sant Pau study reveals immune system’s crucial role in ALS at cellular level

A recent study from IR Sant Pau investigates the peripheral immune system's role in amyotrophic lateral sclerosis (ALS) at the single-cell level. The research found altered NK cell subpopulations associated with ALS progression, suggesting a potential target for new therapies.

SourceInstitut de Recerca Sant Pau (Sant Pau Research Institute)·JournalJournal of Neuroinflammation·TypeExperimental study·DateFeb 13, 2025

New immune-probing technique could boost treatment discovery

Researchers at Osaka University developed a new technique called single-cell suppressive profiling of regulatory T cells (scSPOT) that can pinpoint the effects of Tregs on all other immune cells. The study found that Tregs most strongly affect CD8-EM T cells, which play a key role in fighting cancer and infections.

SourceOsaka University·JournalNature Communications·TypeExperimental study·DateFeb 12, 2025